Related Experiment Video
Updated: Apr 17, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
MEK guards proteome stability and inhibits tumor-suppressive amyloidogenesis via HSF1
Zijian Tang1, Siyuan Dai2, Yishu He2
1The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA; Graduate Programs, Department of Molecular and Biomedical Sciences, The University of Maine, 5735 Hitchner Hall, Orono, ME 04469, USA.
Abstract:
Signaling through RAS/MAP kinase pathway is central to biology. ERK has long been perceived as the only substrate for MEK. Here, we report that HSF1, the master regulator of the proteotoxic stress response, is a new MEK substrate. Beyond mediating cell-environment interactions, the MEK-HSF1 regulation impacts malignancy. In tumor cells, MEK blockade inactivates HSF1 and thereby provokes proteomic chaos, presented as protein destabilization, aggregation, and, strikingly, amyloidogenesis. Unlike their non-transformed counterparts, tumor cells are particularly susceptible to proteomic perturbation and amyloid induction. Amyloidogenesis is tumor suppressive, reducing in vivo melanoma growth and contributing to the potent anti-neoplastic effects of proteotoxic stressors. Our findings unveil a key biological function of the oncogenic RAS-MEK signaling in guarding proteostasis and suppressing amyloidogenesis. Thus, proteomic instability is an intrinsic feature of malignant state, and disrupting the fragile tumor proteostasis to promote amyloidogenesis may be a feasible therapeutic strategy.
Insights
The RAS/MAP kinase pathway
Area of Science:
- Cellular Biology
- Oncology
- Proteostasis
Background:
- The RAS/MAP kinase pathway is crucial in cell signaling.
- ERK was previously considered the sole MEK substrate.
- The role of MEK in regulating the proteotoxic stress response was unclear.
Purpose of the Study:
- To identify novel MEK substrates.
- To investigate the role of MEK-HSF1 signaling in cancer.
- To explore therapeutic strategies targeting tumor proteostasis.
Main Methods:
- Investigated MEK-HSF1 interaction and regulation.
- Analyzed proteomic changes in tumor cells upon MEK blockade.
- Assessed the impact of amyloidogenesis on tumor growth in vivo.
Main Results:
- HSF1 identified as a novel MEK substrate.
- MEK blockade in tumor cells causes proteomic chaos and amyloidogenesis.
- Tumor cells exhibit heightened susceptibility to proteomic perturbation.
- Amyloidogenesis demonstrates tumor-suppressive effects, inhibiting melanoma growth.
Conclusions:
- Oncogenic RAS-MEK signaling maintains proteostasis and suppresses amyloidogenesis.
- Proteomic instability is inherent to the malignant state.
- Targeting tumor proteostasis to induce amyloidogenesis is a potential anti-cancer strategy.
More Related Videos
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
10:50Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
Related Concept Videos
Abnormal Proliferation
Regulation of the Unfolded Protein Response
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulation of Expression at Multiple Steps
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...